MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

Search

Puma Biotechnology Inc

Закрыт

СекторЗдравоохранение

2.87 1.77

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

2.81

Макс.

2.93

Ключевые показатели

By Trading Economics

Доход

-1M

19M

Продажи

-21M

59M

P/E

Средняя по отрасли

5.103

63.778

Прибыль на акцию

0.43

Рентабельность продаж

32.678

Сотрудники

172

EBITDA

-8.9M

18M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+53% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

1 мая 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

14M

156M

Предыдущая цена открытия

1.1

Предыдущая цена закрытия

2.87

Новостные настроения

By Acuity

34%

66%

97 / 385 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

Puma Biotechnology Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

8 апр. 2025 г., 22:42 UTC

Главные движущие силы рынка

Peabody Energy Shares Climb on Trump Executive Orders Boosting Coal Industry

8 апр. 2025 г., 22:35 UTC

Отчет
Главные движущие силы рынка

Cal-Maine Foods Shares Fall As Justice Dept Probes Egg Prices

8 апр. 2025 г., 21:30 UTC

Отчет

Cal-Maine Foods Cooperating With Justice Dept Probe Into Egg Price Increases -- Update

8 апр. 2025 г., 21:21 UTC

Отчет

Cal-Maine Foods Cooperating With Justice Dept Probe into Egg Price Increases

9 апр. 2025 г., 00:00 UTC

Главные новости

Trump's Tariffs Put Fed Chair Powell in a 'No-Win Situation' -- WSJ

8 апр. 2025 г., 23:45 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

8 апр. 2025 г., 23:45 UTC

Обсуждения рынка

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

8 апр. 2025 г., 23:43 UTC

Обсуждения рынка

Lithium Oversupply Weighs on Price Outlook -- Market Talk

8 апр. 2025 г., 23:43 UTC

Приобретения, слияния, поглощения

Woolworths' Rivals Have Other Options to Source Ready Meals, ACCC Says

8 апр. 2025 г., 23:42 UTC

Обсуждения рынка

Gold Falls on Possible Unwinding of Long Positions to Raise Cash -- Market Talk

8 апр. 2025 г., 23:42 UTC

Приобретения, слияния, поглощения

Beak & Johnston Makes Ready Meals, Pastries for Wholesale, Retail

8 апр. 2025 г., 23:41 UTC

Приобретения, слияния, поглощения

Woolworths' Acquisition Unlikely to Have Substantial Anti-Competitive Effect, ACCC Says

8 апр. 2025 г., 23:40 UTC

Приобретения, слияния, поглощения

Australian Competition and Consumer Commission: Will Not Oppose Transaction

8 апр. 2025 г., 23:39 UTC

Приобретения, слияния, поглощения

Australian Competition Regulator to Allow Woolworths' Acquisition of Beak & Johnston

8 апр. 2025 г., 23:21 UTC

Приобретения, слияния, поглощения

U.S. Steel: $75 per Shr That the Ancora 'Plan' Proposes Is Really an Unrealistic, Distant Future Value Pipedream Rooted Firmly in Fiction >X

8 апр. 2025 г., 23:21 UTC

Приобретения, слияния, поглощения

U.S. Steel: Stockholders Should Be Very Skeptical of Ancora's 'Plan' or That Their Nominees Could or Would Vigorously Fight for the Nippon Steel Deal >X

8 апр. 2025 г., 21:26 UTC

Главные новости

When Coffee Mate Made a 'White Lotus' Piña Colada Creamer, It Had No Idea How the Season Would End -- WSJ

8 апр. 2025 г., 21:26 UTC

Отчет

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

8 апр. 2025 г., 21:18 UTC

Приобретения, слияния, поглощения

Peabody Energy: Remains in Conversation With Anglo Amer to Better Understand Impacts of Event, Preserving All Rights and Protections Under Purchase Agreements >BTU

8 апр. 2025 г., 21:18 UTC

Приобретения, слияния, поглощения

Peabody Energy: Following Ignition Event Last Week at Anglo Amer's Moranbah North Mine, Reviewing Options Related to Acquisition of Steelmaking Coal Assets From Anglo Amer >BTU

8 апр. 2025 г., 21:06 UTC

Главные новости

Stocks Are in Turmoil, but Treasury Yields Are Stubbornly High -- Update

8 апр. 2025 г., 20:50 UTC

Главные новости

Harley-Davidson Seeks New CEO, Facing Sales Slump and Tariffs -- 3rd Update

8 апр. 2025 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

8 апр. 2025 г., 20:50 UTC

Обсуждения рынка

Auto & Transport Roundup: Market Talk

8 апр. 2025 г., 20:40 UTC

Отчет

BYD Stock Soars. It's Catching Up to Tesla in Yet Another Way. -- Barrons.com

8 апр. 2025 г., 20:28 UTC

Отчет

Sandstorm Gold: Will Release 1Q Results on May 6 After Markets Close >SSL.T

8 апр. 2025 г., 20:28 UTC

Отчет

Sandstorm Gold: During Three Mos Ended March 31, Realized Record Preliminary Revenue of $50.1M (20,316 Attributable Gold Equivalent Ounces and $42.8M in Rev for the Comparable Period in 2024) >SSL.T

8 апр. 2025 г., 20:28 UTC

Отчет

Sandstorm Gold: Record Preliminary Total Sales, Royalties, Income From Other Interests of $54.1M for Three Mos Ended March 31 ($42.8M in Total Sales, Royalties, Income From Other Interests for Comparable Period in 2024) >SSL.T

8 апр. 2025 г., 20:28 UTC

Отчет

Sandstorm Gold: During Three Mos Ended March 31, Sold Approximately 18,500 Attributable Gold Equivalent Ounces >SSL.T

8 апр. 2025 г., 20:14 UTC

Главные новости

U.S. Stocks Retreat as Optimism Over Trade Talks Fades -- WSJ

Сравнение c конкурентами

Изменение цены

Puma Biotechnology Inc Прогноз

Целевая цена

By TipRanks

53% рост

Прогноз на 12 месяцев

Средняя 4.33 USD  53%

Максимум 7 USD

Минимум 2 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для Puma Biotechnology Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

3 ratings

1

Покупка

1

Удержание

1

Продажа

Техническая оценка

By Trading Central

2.835 / 2.925Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Strong Bearish Evidence

Долгосрочная

Strong Bearish Evidence

Настроения

By Acuity

97 / 385Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Puma Biotechnology Inc

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.